STOCK TITAN

Vor Bio to Participate in Upcoming Investor Conferences

(Neutral)
(Neutral)
Tags
conferences

Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced its participation in three upcoming investor conferences in New York, NY. The events include:

1. Morgan Stanley 22nd Annual Global Healthcare Conference - 1x1 Investor Meetings on Friday, September 6, 2024

2. Baird 2024 Global Healthcare Conference - Fireside Chat on Wednesday, September 11, 2024, at 7:55am ET

3. Chardan's 8th Annual Genetic Medicines Conference - Fireside Chat on Monday, September 30, 2024, at 4:30pm ET

These conferences provide Vor Bio with opportunities to engage with investors and showcase their latest developments in cell and genome engineering.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – VOR

-3.39%
-3.39% Session move

In the trading session that priced this news, VOR declined 3.39%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference
1x1 Investor Meetings: Friday, September 6, 2024
Location: New York, NY

Baird 2024 Global Healthcare Conference
Fireside Chat: Wednesday, September 11, 2024, at 7:55am ET
Location: New York, NY

Chardan’s 8th Annual Genetic Medicines Conference
Fireside Chat: Monday, September 30, 2024, at 4:30pm ET
Location: New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


FAQ

What investor conferences will Vor Bio (VOR) attend in September 2024?

Vor Bio will attend three investor conferences in September 2024: Morgan Stanley 22nd Annual Global Healthcare Conference, Baird 2024 Global Healthcare Conference, and Chardan's 8th Annual Genetic Medicines Conference.

When and where is Vor Bio's (VOR) fireside chat at the Baird 2024 Global Healthcare Conference?

Vor Bio's fireside chat at the Baird 2024 Global Healthcare Conference is scheduled for Wednesday, September 11, 2024, at 7:55am ET in New York, NY.

What type of company is Vor Bio (VOR)?

Vor Bio (VOR) is a clinical-stage cell and genome engineering company.

Where will the investor conferences Vor Bio (VOR) is attending be held?

All three investor conferences Vor Bio is attending will be held in New York, NY.

What is the date and time of Vor Bio's (VOR) presentation at Chardan's 8th Annual Genetic Medicines Conference?

Vor Bio will participate in a fireside chat at Chardan's 8th Annual Genetic Medicines Conference on Monday, September 30, 2024, at 4:30pm ET.